ICON supports Pfizer and BioNTech on COVID-19 vaccine trial
Trial capabilities key to enabling agility and speed in global study involving 44,000 subjects
Read the press releaseBest CRO at the Vaccine Industry Excellence Awards
Recognises ICON’s long-standing vaccine development expertise.
Read the press releaseICON launches Accellacare
Global research network offering integrated solutions of patient assessments at site and in-home for decentralised trials
Read the press releaseForbes names ICON in list of Best Employers in America for Women
ICON recognised as top employer for women in anonymous survey of 75,000 employees
Read the press release